On Apr. 13, 2020, Emory University developed a sensitive and specific diagnostic antibody, also known as serological tests, that will help determine antibody responses in people who have been infected by COVID-19. The Marcus Foundation provided a $3 million grant to initiate the extensive process to scale up test processing capabilities.